Seres Therapeutics (MCRB) Receivables - Other: 2016-2025
Historic Receivables - Other for Seres Therapeutics (MCRB) over the last 6 years, with Sep 2025 value amounting to $53,000.
- Seres Therapeutics' Receivables - Other was N/A to $53,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $53,000, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is 69.07% down from last year.
- As of Q3 2025, Seres Therapeutics' Receivables - Other stood at $53,000, which was down 81.00% from $279,000 recorded in Q2 2025.
- Seres Therapeutics' 5-year Receivables - Other high stood at $125.0 million for Q1 2023, and its period low was $53,000 during Q3 2025.
- Its 3-year average for Receivables - Other is $18.9 million, with a median of $7.5 million in 2023.
- In the last 5 years, Seres Therapeutics' Receivables - Other skyrocketed by 146.08% in 2024 and then slumped by 98.50% in 2025.
- Over the past 3 years, Seres Therapeutics' Receivables - Other (Quarterly) stood at $8.7 million in 2023, then slumped by 69.07% to $2.7 million in 2024, then tumbled by 98.50% to $53,000 in 2025.
- Its Receivables - Other stands at $53,000 for Q3 2025, versus $279,000 for Q2 2025 and $1.6 million for Q1 2025.